Search results
Results from the WOW.Com Content Network
For the Canadian legal classification, see Controlled Drugs and Substances Act; For the UK legal classification, see Drugs controlled by the UK Misuse of Drugs Act; For the US legal classification, see Controlled Substances Act § Schedules of controlled substances; Pregnancy category is defined using a variety of systems by different jurisdictions
Many drugs have more than one name and, therefore, the same drug may be listed more than once. Brand names and generic names are differentiated by capitalizing brand names. See also the list of the top 100 bestselling branded drugs , ranked by sales.
Loxam (escitalopram) – an antidepressant of the SSRI class; Lunesta (eszopiclone) – a non-benzodiazepine hypnotic; Luvox (fluvoxamine) – an antidepressant of the SSRI class; Loxitane – an antipsychotic used in the treatment of mood disorders and schizophrenia; Lyrica – treats nerve and muscle pain, including fibromyalgia. It can also ...
This list contains 1200 recommendations for 591 drugs and 103 therapeutic equivalents. [20] A separate list for children up to 12 years of age, known as the WHO Model List of Essential Medicines for Children (EMLc), was created in 2007 and is in its 9th edition.
The top 5 best selling pharmaceuticals 2015–2019. Sales in billion USD. [1] Rank ... Drugs with sales above $5 billion in 2015 included: [3] [4] Rank Drug Trade name
(Top) 1 Drugs. 2 See also. 3 Notes. 4 References. Toggle the table of contents. ... Class Drug 9050 opiate Codeine [3] 9334 opiate Dihydroetorphine [4] 9190
List of drugs: A; List of drugs: A–Ab; List of drugs: Ac; List of drugs: Ad–Ak; List of drugs: Al; List of drugs: Am; List of aminorex analogues; List of drugs: An–Ap; List of antileukemic drugs; List of drugs: Aq–Ar; List of arylcyclohexylamines; List of drugs: As–Az
The Top 100 Drugs: Clinical Pharmacology and Practical Prescribing is a pocket-size medical manual focusing on the most commonly prescribed medicines by the British National Health Service (NHS). It was first published by Churchill Livingstone , Elsevier , in 2014, revised in a second edition in 2018, and again in 2022 in a third edition.